Europe — EMA

Oncoplat (Cisplatin)

Cisplatin, the active ingredient in Oncoplat, is a platinum‑based chemotherapy agent presented as a sterile powder for intravenous infusion use.

Cisplatin

Request sourcing

Pack/s

What is Cisplatin?

Cisplatin, the active ingredient in Oncoplat, is a platinum‑based chemotherapy agent presented as a sterile powder for intravenous infusion use. It treats a variety of malignant solid tumours and is administered under the supervision of oncologists.

GNH USA supplies Oncoplat as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Cisplatin used for?

Oncoplat is a platinum‑based chemotherapeutic that interferes … - ... ... ... ... ... ... ........ ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - ... ... ...

What are the side effects of Cisplatin?

Cisplatin therapy is associated with a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea and vomiting: frequent and often severe. - Nephrotoxicity: elevated serum creatinine and reduced glomerular filtration. - Ototaur ... ... ... ... ... ... ... ... ...

What precautions apply to Cisplatin?

The following ...

What does Cisplatin interact with?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →